# Normobaric Oxygen (NBO) Therapy in Acute Migraine

> **NCT01542307** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 22 (actual)

## Conditions studied

- Migraine

## Interventions

- **BIOLOGICAL:** Oxygen
- **BIOLOGICAL:** Room air

## Key facts

- **NCT ID:** NCT01542307
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01542307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01542307, "Normobaric Oxygen (NBO) Therapy in Acute Migraine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01542307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*